Clinical study to probe genetic link to Salmonella diseases

October 1, 2009

(PhysOrg.com) -- Depending on your genes, Salmonella can mean a lot more than food poisoning. In a new clinical study, researchers at The Rockefeller University Hospital are narrowing in on the genetic link that predisposes a person to a set of complications known as severe nontyphoidal salmonellosis (SNTS). The study will analyze medical records and blood samples of SNTS-diagnosed children and may clarify the role of genetics in the immune system’s various responses to Salmonella infection and lead to more efficient treatments for the disease.

Certain strains of are well known for their virulence. Salmonella typhi, for example, causes , which results in more than half a million deaths each year in the developing nations where it is endemic. But S. typhi is a plain-dealing villain.

“The symptoms associated with typhoidal Salmonella are the same regardless of the host’s immunological profile,” says Carolina Prando, a postdoctoral fellow in Jean-Laurent Casanova’s Laboratory of Human Genetics of Infectious Diseases and the co-principal investigator of the study with Research Associate Stephanie Boisson-Dupuis. Nontyphoidal strains, on the other hand, are the con artist of the Salmonella family: They are a frequent culprit behind food poisoning in healthy children, but in children with impaired immunity, can also wreak havoc in any number of organ systems, producing liver or spleen abscesses, bone infections, meningitis or other disease states. “These symptoms are decidedly non-gastroenterological; they are not symptoms normally produced by nontyphoidal Salmonella in healthy children,” says Prando.

Casanova’s laboratory, which moved from the Necker Medical School in Paris to Rockefeller University last year, has for over a decade been one of the world’s major centers of research on human genetic causes of mycobacterial disease. His group has identified six genes whose mutations predispose a person to mycobacterial infection through the disturbance of key signaling pathways of the immune system. The new study aims to find similar disturbances connected to SNTS.

The investigators’ past work has shown that among patients with mutations in the IFN-γ-dependent part of a circuit known as IL-12/23-IFN-γ, there is a five percent incidence of SNTS associated with mycobacterial disease, while more than 50 percent of patients with a mutation in another part of the circuit are predisposed toward development of both mycobacterial and SNTS infections. However, even these known genetic defects do not explain all the cases. A large fraction of children with SNTS — especially children with isolated SNTS without mycobacterial disease — still lack a genetic explanation.

The new study focuses on the pathway of the signaling molecule known as IL-23. Working with data supplied by pediatricians whose patients had presented with SNTS affecting bones, lymph nodes, the central nervous system and other areas, the investigators currently have 40 subjects for the study and aim to gather data on at least 60 more. By mapping out genes involved in the IL-23-dependent pathway, Prando and Boisson-Dupuis hope to pinpoint the genetic cause behind the unexplained cases of SNTS, and to more definitively distinguish the pathways that lead to mycobacterial disease from those that lead to SNTS. “If we are correct, then a known genetic mutation or history of infection in one family member can suggest the right diagnostic testing for other family members,” says Boisson-Dupuis. “Therapeutically, new approaches based on replacing what’s missing in the immune system may be developed.”

Provided by Rockefeller University (news : web)

Related Stories

Recommended for you

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

Study reveals key molecular link in major cell growth pathway

October 19, 2017
A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate growth with how they sense and make available the nutrients required for growth. Their work, which ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.